This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

AZELASTINE HYDROCHLORIDE

Read time: 1 mins
Marketing start date: 18 Nov 2024

Summary of product characteristics


Effective Time

20221013

Version

5

Spl Product Data Elements

AZELASTINE HYDROCHLORIDE AZELASTINE HYDROCHLORIDE AZELASTINE HYDROCHLORIDE AZELASTINE SODIUM CHLORIDE SODIUM PHOSPHATE, DIBASIC, DODECAHYDRATE HYPROMELLOSES EDETATE DISODIUM CITRIC ACID MONOHYDRATE BENZALKONIUM CHLORIDE WATER

Application Number

ANDA091409

Brand Name

AZELASTINE HYDROCHLORIDE

Generic Name

AZELASTINE HYDROCHLORIDE

Product Ndc

70771-1313

Product Type

HUMAN PRESCRIPTION DRUG

Route

NASAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1313-2 Azelastine Hydrochloride Nasal Spray, 137 mcg per spray 30 mL Rx only Azelastine hydrochloride nasal spray

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.